Status:
COMPLETED
Comparison Of The Two Types Of Hemostasis Management Effectiveness : Thromboelastometry (Rotem) Guided Management And Conventional Method In Newborn Congenital Cardiac Surgery Patients
Lead Sponsor:
Başakşehir Çam & Sakura City Hospital
Conditions:
Newborn Cardiac Surgery
Newborn Hemostasis
Eligibility:
All Genders
Up to 30 years
Brief Summary
Sixty consecutive newborn patients who underwent pediatric cardiac surgery from April 2022 to October 2023 at Basaksehir Cam and Sakura City Hospital) were included in this study. Data of eighty-six p...
Detailed Description
Four main scenarios based on clinical observation and ROTEM results were possible: 1. Insignificant bleeding-normal ROTEM; no transfusions 2. Insignificant bleeding-abnormal ROTEM; no transfusions 3....
Eligibility Criteria
Inclusion
- newborn patients who underwent pediatric congenital heart surgery on cardiopulmonary bypass
Exclusion
- the newborn patients who did not need cardiopulmonary bypass during surgery were excluded.
- the newborns whose records are missing were excluded
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06166940
Start Date
March 1 2022
End Date
October 1 2023
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Basaksehir Cam and Sakura City Hospital
Istanbul, Turkey (Türkiye)